| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | STAG1 AIRE HMGA1 CBFA2T3 NCOR1 PARP1 H1-8 TNRC18 SF3B1 PSIP1 H1-3 H1-6 EXO1 TSPYL5 TSPYL4 NIPBL STAG3 VCX | 7.07e-06 | 739 | 145 | 18 | GO:0003682 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | CDKN1B STAG1 CEP295NL MDM1 CHEK1 PTEN NCKAP5L NCOR1 EHHADH INTS13 PKHD1 KIF14 CEP295 MTCL1 OCLN PLK4 HYDIN MYBL2 | 2.59e-06 | 720 | 143 | 18 | GO:0000226 |
| GeneOntologyBiologicalProcess | microtubule-based process | CDKN1B ERBB2 STAG1 CEP295NL MDM1 CHEK1 PTEN NCKAP5L MADD NCOR1 EHHADH INTS13 H1-6 PKHD1 KIF14 CEP295 MTCL1 OCLN BSN PLK4 HYDIN MYBL2 | 3.79e-06 | 1058 | 143 | 22 | GO:0007017 |
| GeneOntologyBiologicalProcess | cell cycle process | CDKN1B SEH1L STAG1 KCTD19 CEP295NL BTBD18 MDM1 MCM2 CHEK1 PTEN USP19 LIG1 NCOR1 INTS13 MDC1 PKHD1 KIF14 ZFYVE26 CEP295 MTCL1 SHCBP1L CDC27 NIPBL PLK4 STAG3 MYBL2 | 6.00e-06 | 1441 | 143 | 26 | GO:0022402 |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | NEBL STAG1 CEP295NL MDM1 RPS14 PTEN NCOR1 LIAT1 CEP295 DHX29 PLK4 VCX MYBL2 | 2.75e-05 | 475 | 143 | 13 | GO:0140694 |
| GeneOntologyBiologicalProcess | regulation of centriole replication | 2.94e-05 | 26 | 143 | 4 | GO:0046599 | |
| GeneOntologyBiologicalProcess | regulation of centrosome duplication | 2.99e-05 | 52 | 143 | 5 | GO:0010824 | |
| GeneOntologyBiologicalProcess | establishment of sister chromatid cohesion | 5.17e-05 | 11 | 143 | 3 | GO:0034085 | |
| GeneOntologyBiologicalProcess | nucleosome organization | 6.06e-05 | 142 | 143 | 7 | GO:0034728 | |
| GeneOntologyBiologicalProcess | regulation of centrosome cycle | 7.60e-05 | 63 | 143 | 5 | GO:0046605 | |
| GeneOntologyBiologicalProcess | chromosome organization | SEH1L STAG1 MCM2 HMGA1 PARP1 H1-8 H1-3 H1-6 EXO1 KIF14 SHCBP1L CDC27 NIPBL STAG3 MYBL2 | 8.61e-05 | 686 | 143 | 15 | GO:0051276 |
| GeneOntologyBiologicalProcess | chromatin organization | MCM2 CHEK1 HMGA1 BCOR NCOR1 H1-8 SF3B1 PSME4 PSIP1 MDC1 H1-3 H1-6 TSPYL5 TSPYL4 TET3 NIPBL VCX | 1.61e-04 | 896 | 143 | 17 | GO:0006325 |
| GeneOntologyBiologicalProcess | nucleosome assembly | 2.09e-04 | 122 | 143 | 6 | GO:0006334 | |
| GeneOntologyBiologicalProcess | nuclear division | CDKN1B SEH1L STAG1 KCTD19 BTBD18 CHEK1 PTEN KIF14 SHCBP1L NIPBL STAG3 MYBL2 | 2.41e-04 | 512 | 143 | 12 | GO:0000280 |
| GeneOntologyBiologicalProcess | centrosome duplication | 2.51e-04 | 81 | 143 | 5 | GO:0051298 | |
| GeneOntologyBiologicalProcess | DNA recombination | 2.53e-04 | 368 | 143 | 10 | GO:0006310 | |
| GeneOntologyCellularComponent | microtubule organizing center | CDC42BPG CEP295NL MDM1 CDH23 CHEK1 NCKAP5L RABL6 ORC2 PKHD1 ZFYVE26 CEP295 HERC2 CDC27 TSGA10IP MLPH PLK4 DCAF12 PDZD2 | 6.30e-05 | 919 | 144 | 18 | GO:0005815 |
| GeneOntologyCellularComponent | chromosomal region | SEH1L STAG1 MCM2 CHEK1 THOC2 THOC5 ORC2 PARP1 PKHD1 MTCL1 STAG3 | 1.65e-04 | 421 | 144 | 11 | GO:0098687 |
| GeneOntologyCellularComponent | centrosome | CDC42BPG CEP295NL MDM1 CDH23 CHEK1 NCKAP5L RABL6 ORC2 PKHD1 ZFYVE26 CEP295 CDC27 PLK4 DCAF12 PDZD2 | 2.83e-04 | 770 | 144 | 15 | GO:0005813 |
| GeneOntologyCellularComponent | THO complex | 6.94e-04 | 6 | 144 | 2 | GO:0000347 | |
| GeneOntologyCellularComponent | THO complex part of transcription export complex | 6.94e-04 | 6 | 144 | 2 | GO:0000445 | |
| GeneOntologyCellularComponent | cochlear hair cell ribbon synapse | 6.94e-04 | 6 | 144 | 2 | GO:0098683 | |
| GeneOntologyCellularComponent | germ cell nucleus | 1.12e-03 | 113 | 144 | 5 | GO:0043073 | |
| GeneOntologyCellularComponent | nuclear origin of replication recognition complex | 1.28e-03 | 8 | 144 | 2 | GO:0005664 | |
| GeneOntologyCellularComponent | cytoskeleton of presynaptic active zone | 1.28e-03 | 8 | 144 | 2 | GO:0048788 | |
| GeneOntologyCellularComponent | origin recognition complex | 1.28e-03 | 8 | 144 | 2 | GO:0000808 | |
| GeneOntologyCellularComponent | chromosome, telomeric region | 1.40e-03 | 176 | 144 | 6 | GO:0000781 | |
| GeneOntologyCellularComponent | nuclear body | ZBTB16 STAG1 AIRE PTEN THOC2 REXO1 ZNF106 PARP1 SF3B1 PSME4 INTS13 MDC1 EXO1 ELF4 SCAF11 | 1.44e-03 | 903 | 144 | 15 | GO:0016604 |
| Domain | VCX_VCY | 4.08e-06 | 5 | 140 | 3 | PF15231 | |
| Domain | VCX/VCY1 | 4.08e-06 | 5 | 140 | 3 | IPR026653 | |
| Domain | Phostensin_N | 5.58e-05 | 2 | 140 | 2 | PF13916 | |
| Domain | Phostensin | 5.58e-05 | 2 | 140 | 2 | PF13914 | |
| Domain | Treacle-like_TCS | 5.58e-05 | 2 | 140 | 2 | IPR017859 | |
| Domain | Phostensin/Taperin_PP1-bd_dom | 5.58e-05 | 2 | 140 | 2 | IPR025907 | |
| Domain | Phostensin/Taperin_N_dom | 5.58e-05 | 2 | 140 | 2 | IPR025903 | |
| Domain | PPP1R18/Tprn | 5.58e-05 | 2 | 140 | 2 | IPR026671 | |
| Domain | H15 | 1.12e-04 | 13 | 140 | 3 | SM00526 | |
| Domain | Linker_histone | 1.12e-04 | 13 | 140 | 3 | PF00538 | |
| Domain | H15 | 1.12e-04 | 13 | 140 | 3 | PS51504 | |
| Domain | Histone_H1/H5_H15 | 1.41e-04 | 14 | 140 | 3 | IPR005818 | |
| Domain | HMGA | 1.67e-04 | 3 | 140 | 2 | IPR000116 | |
| Domain | SCD | 3.31e-04 | 4 | 140 | 2 | PS51425 | |
| Domain | SCD | 3.31e-04 | 4 | 140 | 2 | IPR020839 | |
| Domain | STAG | 3.31e-04 | 4 | 140 | 2 | PF08514 | |
| Domain | STAG | 3.31e-04 | 4 | 140 | 2 | IPR013721 | |
| Domain | Alpha_kinase | 8.20e-04 | 6 | 140 | 2 | PF02816 | |
| Domain | Pectin_lyas_fold | 8.20e-04 | 6 | 140 | 2 | IPR012334 | |
| Domain | PbH1 | 8.20e-04 | 6 | 140 | 2 | SM00710 | |
| Domain | MHCK_EF2_kinase | 8.20e-04 | 6 | 140 | 2 | IPR004166 | |
| Domain | Occludin_ELL | 8.20e-04 | 6 | 140 | 2 | IPR010844 | |
| Domain | - | 8.20e-04 | 6 | 140 | 2 | 2.160.20.10 | |
| Domain | ELL/occludin | 8.20e-04 | 6 | 140 | 2 | IPR031176 | |
| Domain | ALPHA_KINASE | 8.20e-04 | 6 | 140 | 2 | PS51158 | |
| Domain | Alpha_kinase | 8.20e-04 | 6 | 140 | 2 | SM00811 | |
| Domain | PbH1 | 8.20e-04 | 6 | 140 | 2 | IPR006626 | |
| Domain | Occludin_ELL | 8.20e-04 | 6 | 140 | 2 | PF07303 | |
| Domain | ARM-like | 9.93e-04 | 270 | 140 | 8 | IPR011989 | |
| Domain | fn3 | 1.40e-03 | 162 | 140 | 6 | PF00041 | |
| Domain | Histone_H5 | 1.52e-03 | 8 | 140 | 2 | IPR005819 | |
| Domain | Pectin_lyase_fold/virulence | 1.52e-03 | 8 | 140 | 2 | IPR011050 | |
| Domain | FN3 | 2.73e-03 | 185 | 140 | 6 | SM00060 | |
| Domain | Znf_FYVE | 2.87e-03 | 38 | 140 | 3 | IPR000306 | |
| Domain | FYVE_2 | 2.94e-03 | 11 | 140 | 2 | PF02318 | |
| Domain | ZF_FYVE | 3.33e-03 | 40 | 140 | 3 | PS50178 | |
| Domain | RABBD | 3.51e-03 | 12 | 140 | 2 | PS50916 | |
| Domain | Rab_BD | 3.51e-03 | 12 | 140 | 2 | IPR010911 | |
| Domain | FN3 | 3.91e-03 | 199 | 140 | 6 | PS50853 | |
| Domain | ARM-type_fold | 4.08e-03 | 339 | 140 | 8 | IPR016024 | |
| Domain | FN3_dom | 4.96e-03 | 209 | 140 | 6 | IPR003961 | |
| Domain | Znf_FYVE_PHD | 5.03e-03 | 147 | 140 | 5 | IPR011011 | |
| Domain | PROTEIN_KINASE_TYR | 6.12e-03 | 97 | 140 | 4 | PS00109 | |
| Domain | Tyr_kinase_AS | 6.12e-03 | 97 | 140 | 4 | IPR008266 | |
| Domain | - | 6.61e-03 | 222 | 140 | 6 | 1.25.10.10 | |
| Domain | NAP_family | 7.05e-03 | 17 | 140 | 2 | IPR002164 | |
| Domain | NAP | 7.05e-03 | 17 | 140 | 2 | PF00956 | |
| Pathway | REACTOME_CELL_CYCLE | CDKN1B SEH1L STAG1 MCM2 CHEK1 ORC2 LIG1 PSME4 EHHADH MDC1 EXO1 HERC2 CDC27 NIPBL PLK4 | 1.14e-05 | 603 | 95 | 15 | MM14635 |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 1.40e-05 | 271 | 95 | 10 | MM15388 | |
| Pathway | REACTOME_CELL_CYCLE | CDKN1B SEH1L STAG1 MCM2 CHEK1 ORC2 LIG1 PSME4 MDC1 EXO1 HERC2 CDC27 NIPBL PLK4 STAG3 MYBL2 | 1.45e-05 | 694 | 95 | 16 | M543 |
| Pathway | WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR | 1.73e-05 | 81 | 95 | 6 | M39490 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 2.59e-05 | 291 | 95 | 10 | M16647 | |
| Pathway | REACTOME_G2_M_CHECKPOINTS | 5.01e-05 | 143 | 95 | 7 | MM15383 | |
| Pathway | REACTOME_S_PHASE | 5.72e-05 | 146 | 95 | 7 | MM15378 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 7.50e-05 | 65 | 95 | 5 | M39682 | |
| Pathway | REACTOME_EARLY_PHASE_OF_HIV_LIFE_CYCLE | 1.02e-04 | 14 | 95 | 3 | M4280 | |
| Pathway | REACTOME_S_PHASE | 1.14e-04 | 163 | 95 | 7 | M3158 | |
| Pathway | REACTOME_G2_M_CHECKPOINTS | 1.33e-04 | 167 | 95 | 7 | M19381 | |
| Pathway | WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER | 1.56e-04 | 16 | 95 | 3 | M39391 | |
| Pathway | WP_CELL_CYCLE | 1.57e-04 | 120 | 95 | 6 | M39650 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 1.68e-04 | 77 | 95 | 5 | M27226 | |
| Pathway | KEGG_CELL_CYCLE | 1.97e-04 | 125 | 95 | 6 | M7963 | |
| Pathway | BIOCARTA_MCM_PATHWAY | 2.25e-04 | 18 | 95 | 3 | M6682 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 2.54e-04 | 84 | 95 | 5 | MM14929 | |
| Pathway | PID_HES_HEY_PATHWAY | 3.00e-04 | 48 | 95 | 4 | M288 | |
| Pathway | WP_TROP2_REGULATORY_SIGNALING | 3.25e-04 | 49 | 95 | 4 | M46458 | |
| Pathway | REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV_1_INFECTION | 4.43e-04 | 5 | 95 | 2 | M27040 | |
| Pathway | WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM | 5.07e-04 | 55 | 95 | 4 | M39598 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | CDKN1B UBR1 TCOF1 MCM2 HMGA1 BCOR THOC2 REXO1 USP19 LIG1 NCOR1 ZNF106 SF3B1 PSIP1 ZNF644 MDC1 EXO1 PPP1R18 SCAF11 SPEN DHX29 NIPBL ZNF687 MYBL2 | 4.26e-14 | 774 | 150 | 24 | 15302935 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SEH1L TCOF1 RPS14 HMGA1 BCOR THOC2 THOC5 ZNF512B ORC2 NCOR1 ZNF106 PARP1 SF3B1 PSIP1 INTS13 ZNF644 MDC1 H1-6 EXO1 ELF4 SCAF11 CDC27 SPEN TET3 NIPBL RAI1 ZNF687 NOL8 MYBL2 | 2.74e-13 | 1294 | 150 | 29 | 30804502 |
| Pubmed | 1.66e-09 | 5 | 150 | 4 | 10607842 | ||
| Pubmed | CDK8 FBRS BCOR ZNF512B ORC2 NCOR1 TNRC18 INTS13 MDC1 NIPBL PRRC2B RAI1 | 2.30e-09 | 268 | 150 | 12 | 33640491 | |
| Pubmed | TPRN HMGA1 BCOR PTEN SLC30A1 NCKAP5L FAM27E3 PTPRT MADD ZNF512B USP31 NCOR1 PARP1 PTPRD PLCL2 PPP1R18 KIF14 RELL1 HERC2 PLK4 PRRC2B | 5.44e-09 | 1049 | 150 | 21 | 27880917 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | STAG1 BCOR ZNF512B ORC2 PARP1 PSIP1 ZNF644 MDC1 PUM3 SCAF11 HERC2 CDC27 SPEN NIPBL RAI1 MYBL2 | 9.89e-09 | 608 | 150 | 16 | 36089195 |
| Pubmed | CDK8 ERBB2 TCOF1 TPRN BTBD18 FBRS CHEK1 BCOR NCKAP5L ZNF512B ZNF469 ARHGEF40 INTS13 CEP295 MTO1 CDC27 VAV1 SLC39A7 PRRC2B RAI1 ZNF687 | 1.58e-08 | 1116 | 150 | 21 | 31753913 | |
| Pubmed | RIMS3 USP19 MADD USP31 ZNF644 RABGAP1L PLCL2 LRRC7 MTCL1 SPEN TET3 PRRC2B PDZD2 | 2.75e-08 | 407 | 150 | 13 | 12693553 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | CDKN1B SEH1L STAG1 CHEK1 HMGA1 ORC2 ZNF106 SF3B1 SYTL4 ZNF644 PPP1R18 KIF14 MTCL1 HERC2 CDC27 NIPBL PLK4 PRRC2B LRRFIP2 MYBL2 DCAF12 | 2.85e-08 | 1155 | 150 | 21 | 20360068 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | RPS14 HMGA1 BCOR THOC2 ZNF512B ORC2 NCOR1 PARP1 SF3B1 PSIP1 ZNF644 MDC1 PUM3 SCAF11 SPEN NIPBL RAI1 NOL8 MYBL2 | 3.36e-08 | 954 | 150 | 19 | 36373674 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ERBB2 FBRS REXO1 MADD RABL6 HIVEP3 NCOR1 TNRC18 HEG1 ARHGEF40 PSME4 SYNJ1 KCNQ2 ZFYVE26 HERC2 SPEN PRRC2B RAI1 ZNF687 MYBL2 | 6.76e-08 | 1105 | 150 | 20 | 35748872 |
| Pubmed | FN1 TCOF1 RPS14 THOC2 SF3B1 MDC1 H1-3 KIF14 PUM3 SCAF11 HERC2 SPEN NIPBL PRRC2B RAI1 | 1.70e-07 | 653 | 150 | 15 | 22586326 | |
| Pubmed | 3.14e-07 | 4 | 150 | 3 | 10903929 | ||
| Pubmed | CDK8 SEH1L CHEK1 HMGA1 BCOR THOC2 LIG1 NCOR1 PARP1 TNRC18 PSIP1 ZNF644 PUM3 SPEN NIPBL PRRC2B RAI1 ZNF687 MYBL2 | 3.15e-07 | 1103 | 150 | 19 | 34189442 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | FBRS BCOR ZNF512B NCOR1 TNRC18 ZNF644 MDC1 SPEN NIPBL PRRC2B RAI1 | 4.04e-07 | 351 | 150 | 11 | 38297188 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 4.67e-07 | 283 | 150 | 10 | 30585729 | |
| Pubmed | NYAP2 FBRS BCOR NCOR1 INTS13 CEP295 MTCL1 BSN SPEN NIPBL PRRC2B RAI1 ZNF687 MYBL2 | 7.71e-07 | 638 | 150 | 14 | 31182584 | |
| Pubmed | Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women. | 8.06e-07 | 170 | 150 | 8 | 19064572 | |
| Pubmed | 8.52e-07 | 233 | 150 | 9 | 37704626 | ||
| Pubmed | FN1 STAG1 TCOF1 RPS14 MCM2 HMGA1 THOC2 THOC5 PARP1 SF3B1 PSIP1 MDC1 PUM3 NIPBL | 9.95e-07 | 652 | 150 | 14 | 31180492 | |
| Pubmed | 1.25e-06 | 79 | 150 | 6 | 14729942 | ||
| Pubmed | FN1 TCOF1 RPS14 SLC30A1 USP19 RABL6 LIG1 NCOR1 SF3B1 SYTL4 RELL1 OCLN SPEN PRRC2B NOL8 | 1.50e-06 | 777 | 150 | 15 | 35844135 | |
| Pubmed | 1.56e-06 | 6 | 150 | 3 | 12941272 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | TCOF1 TPRN FBRS BCOR NCKAP5L NCOR1 SYNJ1 ZNF644 KIF14 BSN SPEN PRRC2B MYBL2 | 1.79e-06 | 588 | 150 | 13 | 38580884 |
| Pubmed | FBRS CHEK1 BCOR NCOR1 SYNJ1 ZNF644 KIF14 GPRASP2 SLC39A7 ZNF687 MYBL2 | 2.22e-06 | 418 | 150 | 11 | 34709266 | |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | ERBB2 TCOF1 BTBD18 HMGA1 PTEN PTPRT USP31 PARP1 HERC2 SPEN SLC39A7 | 2.32e-06 | 420 | 150 | 11 | 28065597 |
| Pubmed | 2.44e-06 | 340 | 150 | 10 | 29478914 | ||
| Pubmed | 2.76e-06 | 23 | 150 | 4 | 19343178 | ||
| Pubmed | ATRX proximal protein associations boast roles beyond histone deposition. | 2.87e-06 | 91 | 150 | 6 | 34780483 | |
| Pubmed | CTU2 TCOF1 RPS14 MCM2 HMGA1 DARS2 NCOR1 ZNF106 PARP1 ARHGEF40 SF3B1 PSIP1 MDC1 MTCL1 CDC27 NIPBL SDC4 SLC39A7 PRRC2B | 3.44e-06 | 1297 | 150 | 19 | 33545068 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | SEH1L TCOF1 FBRS MCM2 PARP1 MDC1 PUM3 HERC2 CDC27 DHX29 ZNF687 | 3.62e-06 | 440 | 150 | 11 | 34244565 |
| Pubmed | SEH1L TCOF1 RPS14 MCM2 THOC2 ZNF512B NCOR1 PSIP1 MDC1 PUM3 SCAF11 SLC39A7 ZNF687 LRRFIP2 NOL8 | 4.29e-06 | 847 | 150 | 15 | 35850772 | |
| Pubmed | NYAP2 TCOF1 BCOR NCOR1 PARP1 SF3B1 PTPRD SYNJ1 LRRC7 MTCL1 HERC2 BSN NIPBL PRRC2B RAI1 LRRFIP2 | 4.54e-06 | 963 | 150 | 16 | 28671696 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ERBB2 ZBTB16 ABL2 CARMIL2 CHEK1 NCKAP5L MADD USP31 ZNF106 SYNJ1 RABGAP1L EXO1 KIF14 MTCL1 PLK4 | 5.22e-06 | 861 | 150 | 15 | 36931259 |
| Pubmed | ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. | 5.40e-06 | 27 | 150 | 4 | 17525332 | |
| Pubmed | SCML2 establishes the male germline epigenome through regulation of histone H2A ubiquitination. | 5.40e-06 | 27 | 150 | 4 | 25703348 | |
| Pubmed | 5.87e-06 | 222 | 150 | 8 | 37071664 | ||
| Pubmed | 5.90e-06 | 103 | 150 | 6 | 32744500 | ||
| Pubmed | ZBTB16 FN1 STAG1 TPRN RPS14 ZNF512B NCOR1 ZNF106 SF3B1 PLCL2 HERC2 PCDH1 | 1.07e-05 | 591 | 150 | 12 | 15231748 | |
| Pubmed | Role of H1 linker histones in mammalian development and stem cell differentiation. | 1.26e-05 | 11 | 150 | 3 | 26689747 | |
| Pubmed | TCOF1 MCM2 THOC2 LIG1 NCOR1 SF3B1 MTCL1 SPEN DHX29 NIPBL ZNF687 | 1.27e-05 | 503 | 150 | 11 | 16964243 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | TCOF1 RPS14 ZNF512B PARP1 SF3B1 PSIP1 MDC1 PUM3 SCAF11 SPEN RAI1 ZNF687 | 1.35e-05 | 605 | 150 | 12 | 28977666 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NEBL TCOF1 HMGA1 BCOR THOC2 ZNF512B ORC2 PARP1 SF3B1 PSIP1 SYNJ1 DHX29 NIPBL PRRC2B NOL8 | 1.37e-05 | 934 | 150 | 15 | 33916271 |
| Pubmed | 1.39e-05 | 250 | 150 | 8 | 33536335 | ||
| Pubmed | Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions. | 1.44e-05 | 71 | 150 | 5 | 28319113 | |
| Pubmed | CYLC1 STAG1 HMGA1 NCOR1 PARP1 TNRC18 SF3B1 PSIP1 H1-3 H1-6 PKHD1 CEP295 BSN CDC27 SPEN MLPH NIPBL PRRC2B RAI1 | 1.54e-05 | 1442 | 150 | 19 | 35575683 | |
| Pubmed | 1.55e-05 | 72 | 150 | 5 | 31248990 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 1.63e-05 | 123 | 150 | 6 | 26912792 | |
| Pubmed | A unified phylogeny-based nomenclature for histone variants. | 1.68e-05 | 12 | 150 | 3 | 22650316 | |
| Pubmed | A stronger DNA damage-induced G2 checkpoint due to over-activated CHK1 in the absence of PARP-1. | 1.85e-05 | 2 | 150 | 2 | 17102615 | |
| Pubmed | Differential Akt signalling in non-seminomatous testicular germ cell tumors. | 1.85e-05 | 2 | 150 | 2 | 22110200 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 32588888 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 20372838 | ||
| Pubmed | Dasatinib inhibits mammary tumour development in a genetically engineered mouse model. | 1.85e-05 | 2 | 150 | 2 | 23616343 | |
| Pubmed | Let-7 Status Is Crucial for PARP1 Expression in HER2-Overexpressing Breast Tumors. | 1.85e-05 | 2 | 150 | 2 | 28031413 | |
| Pubmed | PTEN and p27 expression in mature T-cell and NK-cell neoplasms. | 1.85e-05 | 2 | 150 | 2 | 16194892 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 30358612 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 20608352 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 25472613 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 26522776 | ||
| Pubmed | HER2 Ile655Val and PTEN IVS4 polymorphisms in patients with breast cancer. | 1.85e-05 | 2 | 150 | 2 | 23086302 | |
| Pubmed | MADD is a downstream target of PTEN in triggering apoptosis. | 1.85e-05 | 2 | 150 | 2 | 24038283 | |
| Pubmed | Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse. | 1.85e-05 | 2 | 150 | 2 | 11175795 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 21264218 | ||
| Pubmed | Involvement of poly(ADP-ribose) polymerase 1 in ERBB2 expression in rheumatoid synovial cells. | 1.85e-05 | 2 | 150 | 2 | 15743888 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 10918569 | ||
| Pubmed | Suppression of CHK1 by ETS Family Members Promotes DNA Damage Response Bypass and Tumorigenesis. | 1.85e-05 | 2 | 150 | 2 | 25653093 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 12897056 | ||
| Pubmed | erbB2 gene silencing and its effect on PTEN in SACC-83 salivary adenoid cystic carcinoma cells. | 1.85e-05 | 2 | 150 | 2 | 20878123 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 22134241 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 22531343 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 22773664 | ||
| Pubmed | Pten loss promotes MAPK pathway dependency in HER2/neu breast carcinomas. | 1.85e-05 | 2 | 150 | 2 | 26929372 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 28253285 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 19435886 | ||
| Pubmed | PARP Activity Fine-tunes the DNA Replication Choreography of Chk1-depleted Cells. | 1.85e-05 | 2 | 150 | 2 | 33744317 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 31786856 | ||
| Pubmed | PTEN loss and p27 loss differ among morphologic patterns of prostate cancer, including cribriform. | 1.85e-05 | 2 | 150 | 2 | 28504208 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 14534684 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 20473728 | ||
| Pubmed | Structure and expression of the mouse testicular H1 histone gene (H1t). | 1.85e-05 | 2 | 150 | 2 | 8241275 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 32266537 | ||
| Pubmed | PTEN loss inhibits CHK1 to cause double stranded-DNA breaks in cells. | 1.85e-05 | 2 | 150 | 2 | 15970699 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 20676139 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 12684422 | ||
| Pubmed | HER2 overcomes PTEN (loss)-induced senescence to cause aggressive prostate cancer. | 1.85e-05 | 2 | 150 | 2 | 21930937 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 18723495 | ||
| Pubmed | hPuf-A/KIAA0020 modulates PARP-1 cleavage upon genotoxic stress. | 1.85e-05 | 2 | 150 | 2 | 21266351 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 24356582 | ||
| Pubmed | Lack of PTEN sequesters CHK1 and initiates genetic instability. | 1.85e-05 | 2 | 150 | 2 | 15710331 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 19293259 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 16002346 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 25128455 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 25743092 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 24970476 | ||
| Pubmed | PTEN Controls the DNA Replication Process through MCM2 in Response to Replicative Stress. | 1.85e-05 | 2 | 150 | 2 | 26549452 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 23464451 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 25587029 | ||
| Pubmed | HER-2/neu is an independent prognostic factor in type I endometrial adenocarcinoma. | 1.85e-05 | 2 | 150 | 2 | 25022554 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 10744766 | ||
| Interaction | CBX3 interactions | CDK8 FN1 TCOF1 FBRS MCM2 HMGA1 BCOR ZNF512B ORC2 LIG1 NCOR1 PARP1 PSIP1 ZNF644 MDC1 KIF14 SPEN NIPBL PRRC2B NOL8 MYBL2 | 9.90e-09 | 646 | 147 | 21 | int:CBX3 |
| Interaction | HMGA1 interactions | CDK8 FN1 MCM2 HMGA1 BCOR ORC2 PARP1 TNRC18 PSIP1 ZNF644 MDC1 H1-3 KIF14 SCAF11 CDC27 SPEN RAI1 | 1.16e-08 | 419 | 147 | 17 | int:HMGA1 |
| Interaction | H3-3A interactions | STAG1 MCM2 HMGA1 BCOR ZNF512B ORC2 PARP1 SF3B1 PSIP1 ZNF644 MDC1 H1-3 H1-6 TSPYL5 PUM3 SCAF11 HERC2 CDC27 SPEN NIPBL RAI1 MYBL2 | 2.63e-08 | 749 | 147 | 22 | int:H3-3A |
| Interaction | PARP1 interactions | CDK8 FNDC3B ERBB2 ZBTB16 FN1 STAG1 AIRE MCM2 NCK1 CHEK1 HMGA1 PTEN ITFG1 ZNF512B RABL6 LIG1 ZNF106 PARP1 PSIP1 ZNF644 H1-3 SCAF11 MPND NIPBL STAG3 RAI1 NOL8 MYBL2 | 2.63e-07 | 1316 | 147 | 28 | int:PARP1 |
| Interaction | TERF2IP interactions | MCM2 BCOR PTEN THOC2 ZNF512B NCOR1 PARP1 PSIP1 ZNF644 MDC1 SCAF11 MPND SPEN NIPBL RAI1 ZNF687 MYBL2 | 6.01e-07 | 552 | 147 | 17 | int:TERF2IP |
| Interaction | RPL28 interactions | CDC42BPG FNDC3B FN1 TCOF1 RPS14 MCM2 PTEN ITFG1 PTPRD ZNF644 H1-3 KIF14 PUM3 CEP295 GPRASP2 NOL8 | 6.81e-07 | 494 | 147 | 16 | int:RPL28 |
| Interaction | H2BC21 interactions | CYLC1 AIRE MCM2 HMGA1 BCOR ORC2 PARP1 PSIP1 ZNF644 MDC1 H1-3 H1-6 EXO1 SCAF11 CDC27 NIPBL RAI1 ZNF687 LRRFIP2 | 7.76e-07 | 696 | 147 | 19 | int:H2BC21 |
| Interaction | H2BC9 interactions | CYLC1 CEP295NL RPS14 MCM2 HMGA1 PARP1 H1-8 ZNF469 TNRC18 PSIP1 MDC1 H1-3 H1-6 ANKRD36 RAI1 | 9.72e-07 | 446 | 147 | 15 | int:H2BC9 |
| Interaction | ASF1A interactions | MCM2 BCOR THOC2 ZNF512B NCOR1 ZNF644 MDC1 SPEN RAI1 ZNF687 MYBL2 | 2.22e-06 | 249 | 147 | 11 | int:ASF1A |
| Interaction | H1-0 interactions | MCM2 NCK1 HMGA1 BCOR PTEN PARP1 H1-3 ALPK3 CDC27 TSPYL4 RAI1 | 2.90e-06 | 256 | 147 | 11 | int:H1-0 |
| Interaction | AR interactions | CDK8 CDC42BPG ZBTB16 ABL2 FN1 FBRS MCM2 BCOR PTEN ZNF512B ORC2 NCOR1 PARP1 TNRC18 SF3B1 INTS13 MDC1 CDC27 NIPBL VAV1 PRRC2B RAI1 | 3.10e-06 | 992 | 147 | 22 | int:AR |
| Interaction | TOP1 interactions | CDK8 ERBB2 TCOF1 RPS14 MCM2 CHEK1 THOC5 LIG1 PARP1 SF3B1 EXO1 KIF14 TSPYL5 SCAF11 HERC2 DHX29 NIPBL RAI1 | 3.32e-06 | 696 | 147 | 18 | int:TOP1 |
| Interaction | CEBPA interactions | CDK8 BHLHE41 SEH1L ZBTB16 STAG1 RPS14 CHEK1 HMGA1 BCOR THOC2 THOC5 LIG1 NCOR1 PARP1 TNRC18 PSIP1 INTS13 ZNF644 PUM3 SPEN NIPBL PRRC2B RAI1 ZNF687 MYBL2 | 3.59e-06 | 1245 | 147 | 25 | int:CEBPA |
| Interaction | XRCC6 interactions | FN1 MCM2 CHEK1 HMGA1 PTEN THOC2 ITFG1 ZNF512B ORC2 NCOR1 PARP1 TNRC18 SF3B1 PSIP1 INTS13 MDC1 KIF14 SCAF11 SPEN VAV1 NOL8 | 3.90e-06 | 928 | 147 | 21 | int:XRCC6 |
| Interaction | RPL22 interactions | FN1 RPS14 MCM2 PTEN THOC5 ITFG1 PARP1 H1-8 TNRC18 H1-3 KIF14 SCAF11 HERC2 DHX29 | 4.32e-06 | 440 | 147 | 14 | int:RPL22 |
| Interaction | H2BC8 interactions | STAG1 MCM2 HMGA1 BCOR ZNF512B ORC2 PARP1 PSIP1 ZNF644 MDC1 SCAF11 SPEN NIPBL RAI1 ZNF687 MYBL2 | 4.95e-06 | 576 | 147 | 16 | int:H2BC8 |
| Interaction | ERG interactions | FBRS BCOR NCOR1 PARP1 SF3B1 PTPRD FAM218A HERC2 NIPBL PRRC2B | 5.70e-06 | 223 | 147 | 10 | int:ERG |
| Interaction | H1-4 interactions | TCOF1 MCM2 NCK1 HMGA1 ZNF512B RABL6 TNRC18 SF3B1 H1-3 H1-6 KIF14 PUM3 SCAF11 BSN ALPK2 MYBL2 DCAF12 | 6.17e-06 | 656 | 147 | 17 | int:H1-4 |
| Interaction | H3C1 interactions | STAG1 AIRE MCM2 HMGA1 ZNF512B ORC2 NCOR1 PARP1 TNRC18 SF3B1 PSIP1 ZNF644 MDC1 H1-3 H1-6 TSPYL5 CDC27 SPEN NIPBL PDZD2 | 9.01e-06 | 901 | 147 | 20 | int:H3C1 |
| Interaction | RPS27A interactions | FN1 RPS14 MCM2 NCK1 CHEK1 HMGA1 PTEN WDFY4 ITFG1 ZNF512B PARP1 H1-8 TNRC18 H1-3 KCNQ2 | 9.11e-06 | 536 | 147 | 15 | int:RPS27A |
| Interaction | H1-3 interactions | FN1 NCK1 HMGA1 NCOR1 PARP1 TNRC18 SF3B1 H1-3 H1-6 KIF14 PUM3 | 9.80e-06 | 291 | 147 | 11 | int:H1-3 |
| Interaction | YWHAZ interactions | CDKN1B CDC42BPG FNDC3B ERBB2 ABL2 CARMIL2 FN1 RIMS3 MCM2 CHEK1 BCOR NCKAP5L MADD USP31 NCOR1 SF3B1 ZNF644 MDC1 EXO1 KIF14 PUM3 SCAF11 HERC2 PLK4 PSD4 | 9.80e-06 | 1319 | 147 | 25 | int:YWHAZ |
| Interaction | H2AC18 interactions | 1.32e-05 | 148 | 147 | 8 | int:H2AC18 | |
| Interaction | CDC16 interactions | 1.35e-05 | 246 | 147 | 10 | int:CDC16 | |
| Interaction | HDAC1 interactions | BHLHE41 ZBTB16 FN1 STAG1 FBRS AIRE CBFA2T3 BCOR THOC5 USP19 ITFG1 ZNF512B NCOR1 PARP1 TNRC18 SYNJ1 KIF14 SPEN GPRASP2 SLC39A7 RAI1 ZNF687 | 1.77e-05 | 1108 | 147 | 22 | int:HDAC1 |
| Interaction | H2AZ1 interactions | MCM2 NCK1 HMGA1 BCOR PARP1 PSIP1 ZNF644 KIF14 CDC27 PLK4 SDC4 RAI1 | 1.83e-05 | 371 | 147 | 12 | int:H2AZ1 |
| Interaction | H3-5 interactions | 2.04e-05 | 114 | 147 | 7 | int:H3-5 | |
| Interaction | CSNK2A1 interactions | BHLHE41 FN1 TCOF1 FBRS RPS14 MCM2 CHEK1 HMGA1 BCOR PTEN THOC5 ITFG1 LIG1 NCOR1 SF3B1 PSIP1 MDC1 ANKRD36 OCLN ZNF687 | 2.12e-05 | 956 | 147 | 20 | int:CSNK2A1 |
| Interaction | NFIC interactions | 2.43e-05 | 210 | 147 | 9 | int:NFIC | |
| Interaction | H2BC13 interactions | 2.43e-05 | 210 | 147 | 9 | int:H2BC13 | |
| Interaction | ZNF330 interactions | RPS14 HMGA1 ZNF512B ORC2 ZNF106 PARP1 PSIP1 ZNF644 PUM3 CDC27 NIPBL RAI1 NOL8 | 2.43e-05 | 446 | 147 | 13 | int:ZNF330 |
| Interaction | H2BC12 interactions | CYLC1 FN1 MCM2 HMGA1 TNRC18 H1-3 H1-6 KIF14 ANKRD36 PRRC2B NOL8 | 2.51e-05 | 322 | 147 | 11 | int:H2BC12 |
| Interaction | H2BC5 interactions | CYLC1 NEBL TCOF1 MCM2 NCK1 CHEK1 HMGA1 PARP1 H1-8 TNRC18 H1-3 | 3.23e-05 | 331 | 147 | 11 | int:H2BC5 |
| Interaction | H1-5 interactions | CDKN1B FN1 RPS14 CCDC168 HMGA1 PARP1 SF3B1 H1-3 H1-6 KIF14 PUM3 BSN MYBL2 | 3.58e-05 | 463 | 147 | 13 | int:H1-5 |
| Interaction | CBX2 interactions | 3.90e-05 | 126 | 147 | 7 | int:CBX2 | |
| Interaction | PHC1 interactions | 3.96e-05 | 86 | 147 | 6 | int:PHC1 | |
| Interaction | SSRP1 interactions | AIRE MCM2 PTEN REXO1 THOC5 NCOR1 PARP1 SF3B1 INTS13 ZNF644 EXO1 KIF14 SCAF11 NIPBL RAI1 ZNF687 | 4.16e-05 | 685 | 147 | 16 | int:SSRP1 |
| Interaction | EED interactions | CDC42BPG FN1 STAG1 TCOF1 RPS14 MCM2 HMGA1 BCOR PTEN THOC2 ZNF512B LIG1 NCOR1 PARP1 SF3B1 SYNJ1 MDC1 PUM3 HERC2 SPEN NIPBL VAV1 ZNF687 LRRFIP2 MYBL2 | 4.52e-05 | 1445 | 147 | 25 | int:EED |
| Interaction | SUPT5H interactions | CDKN1B FN1 HMGA1 ZNF512B NCOR1 ZNF106 PARP1 INTS13 KIF14 SCAF11 SPEN NIPBL | 4.63e-05 | 408 | 147 | 12 | int:SUPT5H |
| Interaction | SIRT6 interactions | CDKN1B SEH1L TCOF1 FBRS MCM2 BCOR PTEN PARP1 ZNF644 MDC1 PUM3 HERC2 CDC27 DHX29 ZNF687 | 5.70e-05 | 628 | 147 | 15 | int:SIRT6 |
| Interaction | DBN1 interactions | FN1 TPRN PTEN PARP1 RABGAP1L PPP1R18 KIF14 HERC2 MLPH NIPBL SDC4 LRRFIP2 | 5.71e-05 | 417 | 147 | 12 | int:DBN1 |
| Interaction | TOP3B interactions | ERBB2 FBRS THOC2 MCRIP2 REXO1 MADD RABL6 HIVEP3 NCOR1 TNRC18 HEG1 ARHGEF40 PSME4 PSIP1 SYNJ1 MDC1 KIF14 KCNQ2 ZFYVE26 HERC2 SPEN PRRC2B RAI1 ZNF687 MYBL2 | 5.97e-05 | 1470 | 147 | 25 | int:TOP3B |
| Interaction | CCNA2 interactions | 6.04e-05 | 183 | 147 | 8 | int:CCNA2 | |
| Interaction | MCM5 interactions | FN1 AIRE MCM2 CHEK1 PTEN ORC2 LIG1 PARP1 SF3B1 H1-3 KIF14 GPRASP2 | 6.11e-05 | 420 | 147 | 12 | int:MCM5 |
| Interaction | ERBB4 interactions | 6.27e-05 | 184 | 147 | 8 | int:ERBB4 | |
| Interaction | DSG1 interactions | 6.27e-05 | 184 | 147 | 8 | int:DSG1 | |
| Interaction | FBL interactions | FN1 TCOF1 RPS14 MCM2 PTEN ITFG1 ZNF512B ARHGEF40 ZNF644 KIF14 PUM3 DHX29 PRRC2B NOL8 DCAF12 | 6.92e-05 | 639 | 147 | 15 | int:FBL |
| Interaction | H3C3 interactions | STAG1 MCM2 ZNF512B ORC2 PARP1 ZNF644 MDC1 PUM3 SCAF11 CDC27 SPEN NIPBL RAI1 | 7.07e-05 | 495 | 147 | 13 | int:H3C3 |
| Interaction | SLX4 interactions | BCOR REXO1 ZNF512B NCOR1 ZNF106 PARP1 SF3B1 ZNF644 MDC1 NIPBL PRRC2B ZNF687 NOL8 MYBL2 | 7.86e-05 | 572 | 147 | 14 | int:SLX4 |
| Interaction | KIF20A interactions | SEH1L NEBL RPS14 HMGA1 THOC2 ZNF106 PARP1 SF3B1 PSIP1 RABGAP1L MDC1 H1-3 H1-6 PPP1R18 KIF14 PUM3 HERC2 TET3 STAG3 PRRC2B | 8.08e-05 | 1052 | 147 | 20 | int:KIF20A |
| Interaction | DDA1 interactions | STAG1 MCM2 ZNF407 HMGA1 ZNF512B PARP1 PSIP1 ZFHX2 KIF14 SCAF11 DCAF12 | 8.38e-05 | 368 | 147 | 11 | int:DDA1 |
| Interaction | H2AC6 interactions | 9.23e-05 | 100 | 147 | 6 | int:H2AC6 | |
| Interaction | FBXO38 interactions | 9.50e-05 | 145 | 147 | 7 | int:FBXO38 | |
| Interaction | ARL4D interactions | 9.91e-05 | 146 | 147 | 7 | int:ARL4D | |
| Interaction | CRX interactions | 1.06e-04 | 254 | 147 | 9 | int:CRX | |
| Interaction | DBF4 interactions | 1.06e-04 | 34 | 147 | 4 | int:DBF4 | |
| Interaction | H3-4 interactions | CEP295NL AIRE MCM2 HMGA1 REXO1 USP19 ORC2 PARP1 H1-3 H1-6 HERC2 TSPYL4 | 1.13e-04 | 448 | 147 | 12 | int:H3-4 |
| Interaction | CFL1 interactions | CYLC1 FNDC3B ERBB2 FN1 MCM2 PTEN LIG1 KIF14 SPEN TSGA10IP VAV1 | 1.22e-04 | 384 | 147 | 11 | int:CFL1 |
| Interaction | SDF4 interactions | 1.22e-04 | 151 | 147 | 7 | int:SDF4 | |
| Interaction | FEV interactions | 1.24e-04 | 203 | 147 | 8 | int:FEV | |
| Interaction | SMC5 interactions | RPS14 HMGA1 BCOR THOC2 ZNF512B ORC2 NCOR1 PARP1 SF3B1 PSIP1 ZNF644 MDC1 PUM3 SCAF11 SPEN NIPBL RAI1 NOL8 MYBL2 | 1.25e-04 | 1000 | 147 | 19 | int:SMC5 |
| Interaction | DPY30 interactions | 1.29e-04 | 204 | 147 | 8 | int:DPY30 | |
| Interaction | RPL31 interactions | FN1 TCOF1 RPS14 MCM2 PTEN ITFG1 ZNF512B ZNF106 SF3B1 H1-3 H1-6 KIF14 TSPYL5 PUM3 NOL8 | 1.38e-04 | 680 | 147 | 15 | int:RPL31 |
| Interaction | NCOR2 interactions | 1.42e-04 | 264 | 147 | 9 | int:NCOR2 | |
| Interaction | H3C15 interactions | 1.42e-04 | 207 | 147 | 8 | int:H3C15 | |
| Interaction | MED23 interactions | 1.50e-04 | 266 | 147 | 9 | int:MED23 | |
| Interaction | DCPS interactions | SEH1L RPS14 HMGA1 THOC2 PARP1 SF3B1 PSIP1 MDC1 PUM3 CDC27 NIPBL | 1.53e-04 | 394 | 147 | 11 | int:DCPS |
| Interaction | LMNB1 interactions | ZBTB16 FN1 AIRE MCM2 HMGA1 PTEN THOC2 ZNF512B PARP1 H1-3 KIF14 PUM3 HERC2 NIPBL | 1.54e-04 | 610 | 147 | 14 | int:LMNB1 |
| Interaction | IRF2BP2 interactions | 1.56e-04 | 110 | 147 | 6 | int:IRF2BP2 | |
| Interaction | CTDSPL2 interactions | 1.59e-04 | 70 | 147 | 5 | int:CTDSPL2 | |
| Interaction | PAX8 interactions | 1.64e-04 | 111 | 147 | 6 | int:PAX8 | |
| Interaction | CHD4 interactions | TCOF1 RPS14 MCM2 HMGA1 PTEN ZNF512B RABL6 PARP1 SF3B1 PSIP1 ZNF644 MDC1 PUM3 SCAF11 SPEN RAI1 ZNF687 MYBL2 | 1.68e-04 | 938 | 147 | 18 | int:CHD4 |
| Interaction | PPP1CA interactions | SEH1L FN1 TPRN RPS14 PTEN WDFY4 ITFG1 NCOR1 SF3B1 MDC1 PLCL2 PPP1R18 KIF14 LRRC7 HERC2 | 1.77e-04 | 696 | 147 | 15 | int:PPP1CA |
| Interaction | MEN1 interactions | STAG1 TCOF1 RPS14 MCM2 CHEK1 THOC2 DARS2 ZNF512B ORC2 NCOR1 PSIP1 ZNF644 MDC1 PUM3 SCAF11 SPEN SLC39A7 ZNF687 NOL8 | 1.80e-04 | 1029 | 147 | 19 | int:MEN1 |
| Interaction | ARL15 interactions | 1.81e-04 | 113 | 147 | 6 | int:ARL15 | |
| Interaction | EPHB2 interactions | 1.91e-04 | 216 | 147 | 8 | int:EPHB2 | |
| Interaction | HDAC2 interactions | ZBTB16 STAG1 AIRE HMGA1 CBFA2T3 USP19 ZNF512B NCOR1 PARP1 ZNF644 H1-3 KIF14 HERC2 SPEN RAI1 ZNF687 MYBL2 | 1.95e-04 | 865 | 147 | 17 | int:HDAC2 |
| Interaction | TMEM33 interactions | 1.96e-04 | 163 | 147 | 7 | int:TMEM33 | |
| Interaction | TBXT interactions | 2.09e-04 | 116 | 147 | 6 | int:TBXT | |
| Interaction | TRRAP interactions | CDK8 SEH1L TCOF1 MCM2 NCK1 ZNF512B NCOR1 PARP1 H1-8 MDC1 H1-3 KIF14 ELF4 STAG3 SLC39A7 LRRFIP2 | 2.17e-04 | 790 | 147 | 16 | int:TRRAP |
| Interaction | GUSBP5 interactions | 2.21e-04 | 75 | 147 | 5 | int:GUSBP5 | |
| Interaction | HSP90AB1 interactions | ERBB2 ABL2 FN1 EPHA6 AIRE MCM2 PTEN THOC2 WDFY4 USP19 ITFG1 PARP1 TNRC18 PSIP1 KIF14 SCAF11 SPEN TET3 | 2.24e-04 | 960 | 147 | 18 | int:HSP90AB1 |
| Interaction | SEC23B interactions | 2.30e-04 | 222 | 147 | 8 | int:SEC23B | |
| Interaction | MCM7 interactions | CDKN1B FN1 MCM2 CHEK1 HMGA1 PTEN ORC2 PARP1 SF3B1 KIF14 DCAF12 | 2.34e-04 | 414 | 147 | 11 | int:MCM7 |
| Interaction | SEC61A1 interactions | 2.37e-04 | 223 | 147 | 8 | int:SEC61A1 | |
| Interaction | SULF2 interactions | 2.40e-04 | 119 | 147 | 6 | int:SULF2 | |
| Interaction | RPL10A interactions | FN1 RPS14 MCM2 NCK1 PTEN THOC2 ITFG1 H1-6 KIF14 PUM3 SPEN NOL8 | 2.57e-04 | 490 | 147 | 12 | int:RPL10A |
| Interaction | CLTA interactions | FN1 RPS14 WDFY4 ITFG1 RABL6 SYNJ1 RABGAP1L KIF14 HERC2 MYBL2 | 2.60e-04 | 351 | 147 | 10 | int:CLTA |
| Interaction | EGR2 interactions | 2.63e-04 | 171 | 147 | 7 | int:EGR2 | |
| Interaction | NR3C1 interactions | UBR1 NYAP2 ZBTB16 FBRS BCOR PTEN NCOR1 PARP1 INTS13 CEP295 MTCL1 BSN SPEN NIPBL PRRC2B RAI1 ZNF687 MYBL2 | 2.66e-04 | 974 | 147 | 18 | int:NR3C1 |
| Interaction | CBX5 interactions | 2.91e-04 | 356 | 147 | 10 | int:CBX5 | |
| Interaction | PCNA interactions | FN1 TCOF1 AIRE MCM2 CHEK1 PTEN ITFG1 LIG1 PARP1 EXO1 CDC27 NIPBL | 2.93e-04 | 497 | 147 | 12 | int:PCNA |
| Interaction | H1-8 interactions | 2.94e-04 | 44 | 147 | 4 | int:H1-8 | |
| Interaction | RBBP4 interactions | FN1 STAG1 MCM2 HMGA1 BCOR ITFG1 ZNF512B NCOR1 TNRC18 KIF14 SPEN RAI1 MYBL2 | 2.98e-04 | 573 | 147 | 13 | int:RBBP4 |
| Interaction | RPL27 interactions | TCOF1 RPS14 MCM2 PTEN ITFG1 PARP1 H1-8 SF3B1 KIF14 PUM3 RAI1 | 3.30e-04 | 431 | 147 | 11 | int:RPL27 |
| Interaction | SRCAP interactions | 3.41e-04 | 127 | 147 | 6 | int:SRCAP | |
| Interaction | RNF123 interactions | A1BG CDKN1B CDC42BPG FN1 RPS14 HMGA1 USP19 DARS2 PSIP1 PKHD1 CHRD CEP295 LRRC7 MTCL1 RAI1 LRRFIP2 | 3.47e-04 | 824 | 147 | 16 | int:RNF123 |
| Interaction | SIRT7 interactions | FN1 TCOF1 RPS14 THOC2 SF3B1 MDC1 H1-3 KIF14 PUM3 SCAF11 HERC2 SPEN NIPBL PRRC2B RAI1 | 3.61e-04 | 744 | 147 | 15 | int:SIRT7 |
| Interaction | PAX6 interactions | VCX2 FBRS BCOR ZNF512B NCOR1 SYNJ1 ZNF644 NIPBL PRRC2B MYBL2 | 3.63e-04 | 366 | 147 | 10 | int:PAX6 |
| Interaction | QPRT interactions | 3.75e-04 | 84 | 147 | 5 | int:QPRT | |
| GeneFamily | Variable charge X/Y family | 1.42e-08 | 6 | 102 | 4 | 368 | |
| GeneFamily | Fibronectin type III domain containing | 2.92e-04 | 160 | 102 | 6 | 555 | |
| GeneFamily | THO complex | 6.50e-04 | 7 | 102 | 2 | 770 | |
| GeneFamily | Cohesin complex | 8.63e-04 | 8 | 102 | 2 | 1060 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.19e-03 | 161 | 102 | 5 | 593 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 3.15e-03 | 15 | 102 | 2 | 26 | |
| GeneFamily | Exonucleases | 3.59e-03 | 16 | 102 | 2 | 544 | |
| Coexpression | HALLMARK_E2F_TARGETS | 2.47e-07 | 200 | 150 | 10 | M5925 | |
| Coexpression | CROONQUIST_IL6_DEPRIVATION_DN | 1.27e-06 | 95 | 150 | 7 | M18506 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | CDKN1B NCK1 ORC2 HEG1 RABGAP1L MDC1 KIF14 SCAF11 MTCL1 SPEN PLK4 | 1.34e-06 | 300 | 150 | 11 | M8702 |
| Coexpression | VEGF_A_UP.V1_DN | 1.79e-06 | 193 | 150 | 9 | M2675 | |
| Coexpression | FUJII_YBX1_TARGETS_DN | 1.87e-06 | 194 | 150 | 9 | M14340 | |
| Coexpression | HALLMARK_G2M_CHECKPOINT | 2.40e-06 | 200 | 150 | 9 | M5901 | |
| Coexpression | BROWNE_HCMV_INFECTION_6HR_DN | 4.90e-06 | 164 | 150 | 8 | M10311 | |
| Coexpression | TBK1.DF_DN | 6.25e-06 | 286 | 150 | 10 | M2864 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CDK8 CDKN1B STAG1 NCK1 PTEN THOC2 ORC2 HEG1 ELL2 PSME4 RABGAP1L KIF14 PUM3 MTCL1 CDC27 SPEN NIPBL | 8.68e-06 | 856 | 150 | 17 | M4500 |
| Coexpression | GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_DN | 2.01e-05 | 199 | 150 | 8 | M4310 | |
| Coexpression | HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_LATE_GENE_EXPR_INDIVID_GENE_MODELS_PRED_PEAK_B_CELL_ELISPOT_RESP_NEGATIVE | 2.14e-05 | 10 | 150 | 3 | M41091 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | A1BG SEH1L TCOF1 MCM2 CHEK1 BCOR THOC5 LIG1 PLCL2 EXO1 KIF14 CEP295 ANKRD36 CDC27 PLK4 STAG3 MYBL2 | 2.83e-05 | 939 | 150 | 17 | M45768 |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | 3.62e-05 | 426 | 150 | 11 | M9516 | |
| Coexpression | CROONQUIST_NRAS_SIGNALING_DN | 5.15e-05 | 70 | 150 | 5 | M10739 | |
| Coexpression | QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_28D_PEAK_T_CELL_RESPONSE_14DY_NEGATIVE | 5.87e-05 | 37 | 150 | 4 | M41132 | |
| Coexpression | MUELLER_PLURINET | 5.91e-05 | 299 | 150 | 9 | M123 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | FN1 STAG1 MCM2 CHEK1 THOC2 USP31 SF3B1 ZNF644 KIF14 PUM3 ELF4 NIPBL PLK4 NOL8 | 7.16e-05 | 721 | 150 | 14 | M10237 |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_UP | 7.79e-05 | 123 | 150 | 6 | M13788 | |
| Coexpression | GSE22611_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_2H_DN | 9.16e-05 | 183 | 150 | 7 | M8178 | |
| Coexpression | BENPORATH_CYCLING_GENES | A1BG CDKN1B RIDA STAG1 MDM1 MCM2 MDC1 EXO1 KIF14 MTCL1 CDC27 NIPBL STAG3 | 9.47e-05 | 648 | 150 | 13 | M8156 |
| Coexpression | GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP | 9.48e-05 | 184 | 150 | 7 | M9005 | |
| Coexpression | NELSON_RESPONSE_TO_ANDROGEN_DN | 1.18e-04 | 17 | 150 | 3 | M16830 | |
| Coexpression | TGFB_UP.V1_DN | 1.20e-04 | 191 | 150 | 7 | M2838 | |
| Coexpression | GSE9946_IMMATURE_VS_MATURE_STIMULATORY_DC_UP | 1.41e-04 | 137 | 150 | 6 | M415 | |
| Coexpression | FISCHER_DREAM_TARGETS | STAG1 TCOF1 MDM1 MCM2 CHEK1 DARS2 ORC2 PSIP1 MDC1 H1-3 EXO1 KIF14 CEP295 NIPBL PLK4 MYBL2 | 1.44e-04 | 969 | 150 | 16 | M149 |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | RIDA UBR1 SEH1L STAG1 RUBCNL MCM2 CHEK1 DARS2 USP31 ORC2 LIG1 PARP1 MDC1 EXO1 KIF14 MTO1 PLK4 VAV1 MYBL2 | 1.49e-04 | 1290 | 150 | 19 | M80 |
| Coexpression | GSE22601_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN | 1.59e-04 | 200 | 150 | 7 | M6252 | |
| Coexpression | GSE24210_CTRL_VS_IL35_TREATED_TCONV_CD4_TCELL_UP | 1.59e-04 | 200 | 150 | 7 | M7841 | |
| Coexpression | GSE14413_UNSTIM_VS_IFNB_STIM_NIH3T3_CELLS_UP | 1.65e-04 | 141 | 150 | 6 | M466 | |
| Coexpression | FORTSCHEGGER_PHF8_TARGETS_DN | UBR1 SEH1L SH3TC2 IGFN1 ABL2 FN1 RPS14 SLC30A1 HEG1 ELL2 RABGAP1L PPP1R18 MTCL1 PRRC2B | 1.70e-04 | 783 | 150 | 14 | M2488 |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_UP | 1.78e-04 | 143 | 150 | 6 | MM989 | |
| Coexpression | FAELT_B_CLL_WITH_VH3_21_DN | 1.79e-04 | 49 | 150 | 4 | M7218 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_CYCLING_DC_CELL | SEH1L CTU2 STAG1 TCOF1 MDM1 MCM2 CHEK1 DARS2 RABL6 ORC2 LIG1 INTS13 MDC1 KIF14 ELF4 CEP295 ANKRD36 CDC27 PLK4 MYBL2 | 1.84e-04 | 1423 | 150 | 20 | M45722 |
| Coexpression | DE_YY1_TARGETS_DN | 1.99e-04 | 93 | 150 | 5 | M3278 | |
| Coexpression | PDGF_UP.V1_UP | 1.99e-04 | 146 | 150 | 6 | M2834 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPERMETHYLATED_AND_DN | 2.27e-04 | 21 | 150 | 3 | M45036 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_CYCLING_DEFINITIVE_ERYTHROBLAST | 2.78e-04 | 450 | 150 | 10 | M45747 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 2.92e-04 | 221 | 150 | 7 | M39222 | |
| Coexpression | LY_AGING_OLD_DN | 3.00e-04 | 56 | 150 | 4 | M18789 | |
| CoexpressionAtlas | B cells, B.GC.Sp, CD19+ IgM+ IgD- GL7+ PNA+, Spleen, avg-3 | RUBCNL MCM2 CHEK1 LIG1 PARP1 ELL2 EXO1 KIF14 PLK4 MYBL2 DCAF12 PDZD2 | 1.39e-05 | 380 | 147 | 12 | GSM538207_500 |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-08 | 192 | 149 | 9 | e8d47504b744040a762ec9b670a66cc060b2ae86 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.58e-08 | 200 | 149 | 9 | fcd16d36f67abf154428242b398b71473f281758 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.58e-08 | 200 | 149 | 9 | b6a016132526e910f95bb40038bbb23f301ca023 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_DZ|normal_Lymph_Node / Location, Cell class and cell subclass | 2.94e-07 | 193 | 149 | 8 | 5ce93860bc60ce6ecfed3a3d985f84e28781eec1 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-07 | 194 | 149 | 8 | 4c1d13d8cb6fb424655c67755ee6dbaf59d6b418 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.06e-07 | 194 | 149 | 8 | 5a519538327029ad2b880ef9647e2ac6ab3961a4 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-07 | 195 | 149 | 8 | 93c345e70d6c8ff5d12fd63d73228c1700b804a0 | |
| ToppCell | tumor_Lung-B_lymphocytes-GC_B_cells_in_the_DZ|B_lymphocytes / Location, Cell class and cell subclass | 3.18e-07 | 195 | 149 | 8 | 339e81a3a5b1f71c0d15ef1ef0f6999378704923 | |
| ToppCell | Healthy/Control-T/NK_proliferative|Healthy/Control / Disease group and Cell class | 3.18e-07 | 195 | 149 | 8 | 957458fdc39723f4a31bd7fd3ce32891aa3fd462 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 3.31e-07 | 196 | 149 | 8 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.31e-07 | 196 | 149 | 8 | 9d4f0a95e49bda25864cbe27e4e86096cba5609f | |
| ToppCell | cycling_basal_cell|World / shred by cell class for nasal brushing | 3.31e-07 | 196 | 149 | 8 | aa7bac70a2fe4a3cb28d89fa1a87c68c2ead1349 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.44e-07 | 197 | 149 | 8 | 4b13335a43b9d6abc8e542e72440da7feb82fbe6 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-Large_pre-B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.44e-07 | 197 | 149 | 8 | cebf47d66f425c84d3fea962e11f5bf4bfe2e60f | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.44e-07 | 197 | 149 | 8 | 21861d8b389fafbdb7c3499684c9b6deee3dbd5e | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.44e-07 | 197 | 149 | 8 | ffb004c37cdd26cb7cdcd80f769a2eded65416dc | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.58e-07 | 198 | 149 | 8 | 2d8d4eb21b4fe3cc178b3518b3ea39c2d9650f24 | |
| ToppCell | Severe-Developping_Plasmablast|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.86e-07 | 200 | 149 | 8 | 6d0cd00e52568d23597cc2a4059bd967d7d2dab5 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.86e-07 | 200 | 149 | 8 | 146f11b521b4b0c2a69f1ee86fb71011c7658914 | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.86e-07 | 200 | 149 | 8 | 04bf9e6a0fbd792b49eed63dabba5d6fafed8c07 | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.86e-07 | 200 | 149 | 8 | f6b5320cdfe640a71e6e2df26f30d42e64b1c921 | |
| ToppCell | (3)_MNP-(3)_DC_Monocyte_Dividing|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.86e-07 | 200 | 149 | 8 | d94fe9bd6ee7c1fed14666f24de41bda014e299b | |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.80e-06 | 171 | 149 | 7 | 13126a3fbee181412c13ffb0c347277b9d8f16f7 | |
| ToppCell | Dividing_Macrophages-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 2.10e-06 | 175 | 149 | 7 | 0a8bf455babb3271aa00642199fb58b0b02dc3ac | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-06 | 176 | 149 | 7 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.54e-06 | 180 | 149 | 7 | 6a2366d76276452141db1bd93013a9503525f574 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-06 | 182 | 149 | 7 | 11494a66d986297b837332ee9d382b71b9f22591 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Cycling_T|Liver / Manually curated celltypes from each tissue | 2.73e-06 | 182 | 149 | 7 | 81557cdc88777f3bd4e1dd18a760b08fc29122ef | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.63e-06 | 190 | 149 | 7 | b65383e256b04122500b742caeed0b807793851e | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.63e-06 | 190 | 149 | 7 | 89095d3e023269d89c82e3a73550f869e3f34201 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.63e-06 | 190 | 149 | 7 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.75e-06 | 191 | 149 | 7 | 15dbc5a03bfab8931c0fd385b0f25874736ae874 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.75e-06 | 191 | 149 | 7 | 45c15f5ce4a207ac944bed65d45f06c1657d1a6d | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.89e-06 | 192 | 149 | 7 | d6f656be2698bd215717d35f4e7ab727c08c61e0 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 3.89e-06 | 192 | 149 | 7 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.02e-06 | 193 | 149 | 7 | bbdfda6665941cfa1965418bb91ef9ff43b1326f | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.16e-06 | 194 | 149 | 7 | f39a471293ecc5c5967b00e772b8f48ebc9affbe | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.16e-06 | 194 | 149 | 7 | 17af04acd54dd6a895a966cbb4422de25dc4f1e6 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-Pro-B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.16e-06 | 194 | 149 | 7 | 3590ff471f74a361ee5bf02a58e3104cd3bf7d00 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.16e-06 | 194 | 149 | 7 | 3c385d93c5fe1a7817813c492f79fdb94d887357 | |
| ToppCell | 3'_v3-blood-Lymphocytic_NK-Cycling_NK|blood / Manually curated celltypes from each tissue | 4.16e-06 | 194 | 149 | 7 | bf9734abaad603ade2a6a6940918aaf1e1c4e2cd | |
| ToppCell | (1)_T_cells_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.16e-06 | 194 | 149 | 7 | 8f313071933451780309d2174ed27d8cdc734343 | |
| ToppCell | Control-Lymphoid_T/NK-T/NK_proliferative|Control / Disease group, lineage and cell class | 4.16e-06 | 194 | 149 | 7 | 9bbb124001fba7450f4639f47f9b720a483e7242 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.16e-06 | 194 | 149 | 7 | 6cc689595a182fbf685fa2f3b9c300f7170fb81f | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.16e-06 | 194 | 149 | 7 | a75ecd0b0a928d4646602f7d16a645f6b3df3af5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.16e-06 | 194 | 149 | 7 | 17744fd6645cf5a447a01a83f07e8d305c2bcd9c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c06-MKI67|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.16e-06 | 194 | 149 | 7 | 5771a28a61f4d9b5479891f3224909ab003cb241 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.16e-06 | 194 | 149 | 7 | 635d0e88f9c542a1d9363066c6cdbc6e44db76c1 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.16e-06 | 194 | 149 | 7 | e14f66f7584909621b776292fbd52808273fd2ee | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.30e-06 | 195 | 149 | 7 | cec7df321f372d05c94f97d6bb18891a5cc3dec3 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 4.30e-06 | 195 | 149 | 7 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | (1)_T_cells-(1)_T_cells_Dividing|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.30e-06 | 195 | 149 | 7 | cf00a0b4f341f0487d5b37810abe2952fdd3f6f2 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.30e-06 | 195 | 149 | 7 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | (4)_B_Hypermutation|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 4.30e-06 | 195 | 149 | 7 | 54d2acaff6be6b5604591bdbd7d769ac3e74f223 | |
| ToppCell | ILEUM-non-inflamed-(1)_Highly_activated_T_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.45e-06 | 196 | 149 | 7 | 6a415a2574bd84bd825a2bd6c8e3632a433ff7cf | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.45e-06 | 196 | 149 | 7 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.45e-06 | 196 | 149 | 7 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | Control-T/NK_proliferative|Control / Disease condition and Cell class | 4.45e-06 | 196 | 149 | 7 | 7b7bc25aef49bfd64f79303a92d527bf8188f7a6 | |
| ToppCell | distal-3-Hematologic-Plasmacytoid_Dendritic|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.45e-06 | 196 | 149 | 7 | 6028b790abba9bad1d5373bab13eb24855988f48 | |
| ToppCell | Mild_COVID-19-T/NK-proliferating_T/NK|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 4.60e-06 | 197 | 149 | 7 | 5fd52fba2cb6fa67377f873da2ff6ce9c83b0591 | |
| ToppCell | Healthy/Control-T/NK_proliferative|World / Disease group and Cell class | 4.60e-06 | 197 | 149 | 7 | 4a4d3083938783d6f5b87da02f10e501917da0b4 | |
| ToppCell | distal-Hematologic-Plasmacytoid_Dendritic-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.60e-06 | 197 | 149 | 7 | 3a5908deb5c5a2bf06019a102fb1652233cf2a2a | |
| ToppCell | COVID-19_Severe-T/NK_proliferative|COVID-19_Severe / Disease condition and Cell class | 4.60e-06 | 197 | 149 | 7 | 718a84e9a8248080f2d964e7c6a3ba183ece9592 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.60e-06 | 197 | 149 | 7 | d7a9296092153cf66426911fecd810f0c1ef978e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.60e-06 | 197 | 149 | 7 | dcff23240bb7cb652d7426b29355aa74442ef6fc | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.60e-06 | 197 | 149 | 7 | 434a5686a103bb766e0d80038413f0e12ea3981a | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.60e-06 | 197 | 149 | 7 | 8b616cde333bdbc0c591035ad9e4949155866245 | |
| ToppCell | Mild-Lymphoid-T-Proliferating_T|Mild / Condition, Lineage, Cell class and cell subclass | 4.60e-06 | 197 | 149 | 7 | 794517c70089da109f4c6489fe406c0ba6882b76 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.60e-06 | 197 | 149 | 7 | 6bddfa199ca812d9e518eaa02c3d4fb67e9f5b16 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.60e-06 | 197 | 149 | 7 | c0a71a9452febda433bc544e4ac0a79c43dcf13e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.60e-06 | 197 | 149 | 7 | f34b1e34f1f0694564031077172c890b233ce8b7 | |
| ToppCell | distal-Hematologic-Proliferating_NK/T-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.60e-06 | 197 | 149 | 7 | 04b10879e48c101d1de449db0bc6b6484090b965 | |
| ToppCell | Healthy_donor-T/NK_proliferative|Healthy_donor / disease group, cell group and cell class (v2) | 4.60e-06 | 197 | 149 | 7 | b6bbf87e5823fa66b4cad6a7be4f777356887b59 | |
| ToppCell | (4)_B_cells-(4)_B_Hypermutation|(4)_B_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 4.76e-06 | 198 | 149 | 7 | 8be724a49b4c911d68c3e82fb75e96722d0eaa03 | |
| ToppCell | (0)_NK_cells-(0)_NK_Dividing|(0)_NK_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.76e-06 | 198 | 149 | 7 | d9cdbc7d420472cb1ffb36ad9c8e53a61b7dbdeb | |
| ToppCell | (3)_DC_Monocyte_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.76e-06 | 198 | 149 | 7 | e2b89f6d7c0007ccab62495cd543fe0e5513a9a4 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_DZ|B_lymphocytes / Location, Cell class and cell subclass | 4.76e-06 | 198 | 149 | 7 | 41e4bc7964a4895dd05bc62f0ef632ce9c89e34f | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 4.76e-06 | 198 | 149 | 7 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Caecum-B_cell-B_cell_cycling|B_cell / Region, Cell class and subclass | 4.76e-06 | 198 | 149 | 7 | d2def132f3efe9305a5501a96ec82efb1f02c3f7 | |
| ToppCell | COVID-19_Severe-T/NK_proliferative|World / disease group, cell group and cell class | 4.76e-06 | 198 | 149 | 7 | 48045689d0969ff0a14eee7086b8e19b0d6b6065 | |
| ToppCell | Immune_cells-large_pre-B.|Immune_cells / Lineage and Cell class | 4.76e-06 | 198 | 149 | 7 | bc9ceefadb153907d2854d1f736d17349003cb31 | |
| ToppCell | (0)_NK_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.76e-06 | 198 | 149 | 7 | 5ebb4965b723302152b42bfaf48bb77a57dd02c5 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.92e-06 | 199 | 149 | 7 | 11c3d9fe811a4619347f47d2b0e94066e3085625 | |
| ToppCell | severe_influenza-T/NK_proliferative|severe_influenza / disease group, cell group and cell class (v2) | 4.92e-06 | 199 | 149 | 7 | 638b1491c47f2884daf1c1d38a779ad8e0f59c52 | |
| ToppCell | mild_COVID-19-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 4.92e-06 | 199 | 149 | 7 | d44cc74d7171d96add61dae821daf774b17d4c69 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.92e-06 | 199 | 149 | 7 | 4394dcd1809f49e9bada8f5e115d5123356eae3e | |
| ToppCell | proximal-Epithelial-Proliferating_Basal|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.92e-06 | 199 | 149 | 7 | 521ff4ae3437c8ba477a0a42b9da195af976c3ff | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.92e-06 | 199 | 149 | 7 | e98ff036d04fc78dffef156bdc0d644532274067 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.92e-06 | 199 | 149 | 7 | 36c80907b2ec1cbcd1b4e841e6c02a4792591d74 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.92e-06 | 199 | 149 | 7 | bf4c31902ae8358215245a2e11b5a2fe4ca1bc8c | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Mild / Disease group, lineage and cell class | 4.92e-06 | 199 | 149 | 7 | ddea0e5c1cb6a096ab8e09a8c3c37c1bff381d9c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.92e-06 | 199 | 149 | 7 | 7feedb0bf84a3361c8ab5b6674ff64e8ff140c23 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.92e-06 | 199 | 149 | 7 | 101f78fe6dd1bf9e2e4dd5ad8a970312b3540927 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.92e-06 | 199 | 149 | 7 | 7beb0e07a27fea94674f24eb61c381b0de38ed3e | |
| ToppCell | NS-critical-d_16-33-Lymphoid-NKT-proliferating|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.92e-06 | 199 | 149 | 7 | 31b144bb209c629e12156f4d9c9cec79baffffb9 | |
| ToppCell | proximal-Epithelial-Proliferating_Basal-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.92e-06 | 199 | 149 | 7 | e8549b2c4152cb23548351d9cee27c3805892cd8 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.92e-06 | 199 | 149 | 7 | 96af1f289552f38f2dfa181192eb3276f4c7d70b | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.92e-06 | 199 | 149 | 7 | 123fbf2122aa221d8cbf3aef9361ba0982c07695 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.92e-06 | 199 | 149 | 7 | e0fcec796afe75e42467ca86355b9fc5aa9ae0a1 | |
| ToppCell | COVID-19_Mild-T/NK_proliferative|COVID-19_Mild / Disease condition and Cell class | 4.92e-06 | 199 | 149 | 7 | 9f9a88d2b099646c1e1a7ee3f8d39cb1a2498ad7 | |
| Disease | Malignant neoplasm of breast | CDKN1B FNDC3B ERBB2 CTU2 FN1 CHEK1 PTEN THOC5 NCOR1 PARP1 PTPRD ZNF644 EXO1 ZFYVE26 LRRC7 HERC2 OCLN CDC27 SPEN NIPBL | 4.13e-07 | 1074 | 147 | 20 | C0006142 |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 1.86e-06 | 41 | 147 | 5 | C0496956 | |
| Disease | Breast adenocarcinoma | 1.86e-06 | 41 | 147 | 5 | C0858252 | |
| Disease | Breast Carcinoma | CDKN1B ERBB2 CTU2 FN1 CHEK1 PTEN NCOR1 PARP1 PTPRD EXO1 HERC2 OCLN | 1.73e-05 | 538 | 147 | 12 | C0678222 |
| Disease | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | 2.41e-05 | 170 | 147 | 7 | EFO_0000685, EFO_0007791, EFO_0007837 | |
| Disease | Colorectal Carcinoma | FN1 TCOF1 CBFA2T3 PTEN ADAMTSL3 PTPRT HIVEP3 LIG1 PARP1 PTPRD INTS13 PKHD1 EXO1 | 5.27e-05 | 702 | 147 | 13 | C0009402 |
| Disease | Mammary Carcinoma, Human | CDKN1B ERBB2 CTU2 FN1 CHEK1 PTEN NCOR1 PARP1 PTPRD EXO1 OCLN | 6.85e-05 | 525 | 147 | 11 | C4704874 |
| Disease | Mammary Neoplasms, Human | CDKN1B ERBB2 CTU2 FN1 CHEK1 PTEN NCOR1 PARP1 PTPRD EXO1 OCLN | 6.85e-05 | 525 | 147 | 11 | C1257931 |
| Disease | Mammary Neoplasms | CDKN1B ERBB2 CTU2 FN1 CHEK1 PTEN NCOR1 PARP1 PTPRD EXO1 OCLN | 7.08e-05 | 527 | 147 | 11 | C1458155 |
| Disease | smoking cessation | 2.35e-04 | 325 | 147 | 8 | EFO_0004319 | |
| Disease | Prostatic Neoplasms | CDKN1B ERBB2 ZBTB16 PTEN NCOR1 PARP1 SF3B1 EHHADH CDC27 SPEN NOL8 | 2.75e-04 | 616 | 147 | 11 | C0033578 |
| Disease | Malignant neoplasm of prostate | CDKN1B ERBB2 ZBTB16 PTEN NCOR1 PARP1 SF3B1 EHHADH CDC27 SPEN NOL8 | 2.75e-04 | 616 | 147 | 11 | C0376358 |
| Disease | keratoconus | 3.35e-04 | 66 | 147 | 4 | MONDO_0015486 | |
| Disease | Pituitary Gland Adenoma | 3.65e-04 | 6 | 147 | 2 | EFO_1000478 | |
| Disease | lymphocyte count | CDKN1B SH3TC2 NYAP2 ZBTB16 CARMIL2 FN1 CDH23 NCK1 HMGA1 PTPRT NCOR1 ZNF469 PSME4 ZNF644 VAV1 RAI1 DCAF12 PSD4 | 3.72e-04 | 1464 | 147 | 18 | EFO_0004587 |
| Disease | Child Development Disorders, Specific | 4.03e-04 | 29 | 147 | 3 | C0085997 | |
| Disease | Child Development Deviations | 4.03e-04 | 29 | 147 | 3 | C0085996 | |
| Disease | Developmental Disabilities | 4.46e-04 | 30 | 147 | 3 | C0008073 | |
| Disease | Malignant Neoplasms | 4.64e-04 | 128 | 147 | 5 | C0006826 | |
| Disease | Profound Mental Retardation | 6.75e-04 | 139 | 147 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 6.75e-04 | 139 | 147 | 5 | C0025363 | |
| Disease | Mental deficiency | 6.75e-04 | 139 | 147 | 5 | C0917816 | |
| Disease | Uterine Neoplasms | 8.67e-04 | 9 | 147 | 2 | C0042138 | |
| Disease | Hepatocellular Adenoma | 8.67e-04 | 9 | 147 | 2 | C0206669 | |
| Disease | central corneal thickness | 9.43e-04 | 309 | 147 | 7 | EFO_0005213 | |
| Disease | Uterine Cancer | 1.08e-03 | 10 | 147 | 2 | C0153567 | |
| Disease | membranoproliferative glomerulonephritis (biomarker_via_orthology) | 1.08e-03 | 10 | 147 | 2 | DOID:2920 (biomarker_via_orthology) | |
| Disease | PR domain zinc finger protein 1 measurement | 1.32e-03 | 11 | 147 | 2 | EFO_0801904 | |
| Disease | Prostatic Intraepithelial Neoplasias | 1.32e-03 | 11 | 147 | 2 | C0282612 | |
| Disease | Macrocephaly | 1.32e-03 | 11 | 147 | 2 | C0221355 | |
| Disease | Malignant neoplasm of kidney | 1.47e-03 | 45 | 147 | 3 | C0740457 | |
| Disease | Acute Promyelocytic Leukemia | 1.57e-03 | 46 | 147 | 3 | C0023487 | |
| Disease | esophageal cancer (is_marker_for) | 1.57e-03 | 12 | 147 | 2 | DOID:5041 (is_marker_for) | |
| Disease | stomach carcinoma (is_implicated_in) | 1.57e-03 | 12 | 147 | 2 | DOID:5517 (is_implicated_in) | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 1.57e-03 | 12 | 147 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | total blood protein measurement | 1.91e-03 | 449 | 147 | 8 | EFO_0004536 | |
| Disease | corneal resistance factor | 1.97e-03 | 451 | 147 | 8 | EFO_0010067 | |
| Disease | urinary bladder cancer (is_marker_for) | 2.05e-03 | 107 | 147 | 4 | DOID:11054 (is_marker_for) | |
| Disease | unipolar depression, anxiety | 2.16e-03 | 14 | 147 | 2 | EFO_0003761, EFO_0005230 | |
| Disease | abdominal adipose tissue measurement | 2.36e-03 | 53 | 147 | 3 | EFO_0803316 | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 2.48e-03 | 15 | 147 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | Carcinoma of Endocrine Gland | 2.48e-03 | 15 | 147 | 2 | C1704374 | |
| Disease | platelet crit | CDKN1B BHLHE41 CTU2 NYAP2 ZBTB16 STAG1 ZNF407 HMGA1 PTEN PARP1 ARHGEF40 CHRD | 2.98e-03 | 952 | 147 | 12 | EFO_0007985 |
| Disease | smoking behavior, BMI-adjusted waist circumference | 3.30e-03 | 122 | 147 | 4 | EFO_0004318, EFO_0007789 | |
| Disease | BMI-adjusted waist circumference, physical activity measurement | 3.39e-03 | 123 | 147 | 4 | EFO_0007789, EFO_0008002 | |
| Disease | BMI-adjusted fasting blood insulin measurement | 3.58e-03 | 18 | 147 | 2 | EFO_0008037 | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 3.87e-03 | 63 | 147 | 3 | DOID:0050866 (is_marker_for) | |
| Disease | renal cell carcinoma (is_marker_for) | 3.91e-03 | 128 | 147 | 4 | DOID:4450 (is_marker_for) | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 3.99e-03 | 19 | 147 | 2 | C1333991 | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 3.99e-03 | 19 | 147 | 2 | C2936783 | |
| Disease | intraocular pressure measurement | 4.10e-03 | 509 | 147 | 8 | EFO_0004695 | |
| Disease | corneal hysteresis | 4.42e-03 | 20 | 147 | 2 | EFO_0010066 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EKRKGRPEPSTKSGG | 221 | Q96MC4 | |
| TLERPKTLSPGKNGV | 1166 | P04626 | |
| RNRSTKVIKPGGPYV | 146 | O00472 | |
| SRVRTVPTRKGAGGK | 266 | Q8TER5 | |
| AKAGRSPEVRSSKPA | 51 | Q96CB5 | |
| GGCVSKRPDVPSLKS | 116 | Q96CB5 | |
| KGAKRPRVTSGGVSE | 271 | O14757 | |
| VTSSGDKDRPRRVKP | 966 | P42684 | |
| KGAGASRVTIKQEPP | 256 | Q9C0J9 | |
| TGSEEVKRKPEAPGS | 1706 | Q86TB3 | |
| GATPVPRTLRKKLGT | 1086 | Q6F5E8 | |
| ESPKGKAPLRARSEG | 646 | Q96L96 | |
| GEKSRTVSSEKPPGL | 981 | A6QL64 | |
| AGSVEQTPKKPGLRR | 181 | P46527 | |
| GIAGEAQSKKPVSRP | 31 | Q7Z478 | |
| RKTAVQDRKDGSSPP | 411 | Q6W2J9 | |
| QVVASDRGTPPRKKD | 1496 | Q9H251 | |
| ARSSSGPKPLVRAKG | 246 | O43918 | |
| QRARVPKPGAGSKLS | 1201 | Q7Z5J4 | |
| GCGTPVEPKFVKRLR | 436 | Q9H714 | |
| PGGVSVRTGPEKRSS | 521 | Q3YEC7 | |
| KAKRGSRAPPARTVG | 161 | Q9Y4B5 | |
| TPSKRAPAKGRAGRS | 376 | Q16625 | |
| PTRKVAKEGGPKVTS | 36 | Q15397 | |
| KAEPVEVVAPRGKSG | 486 | P09874 | |
| LPISTVGTRGKGPKR | 511 | Q9NVM9 | |
| PGKGARTASLESVKP | 271 | Q17RG1 | |
| KSPAPEEKGRVARGS | 1461 | Q6DT37 | |
| SPGKVAAGRLPRSKD | 381 | P49736 | |
| REGETKAVKTVRTPG | 436 | P04217 | |
| PVEVQKGKRPSGRDT | 901 | Q15058 | |
| KGKRPSGRDTPISEG | 906 | Q15058 | |
| DTRAQSGEARKVPPK | 206 | Q8IZA3 | |
| SRKTEAPKGPRKAGL | 316 | Q8IZA3 | |
| RKRSPTESVNTPVGK | 1056 | Q8WXG6 | |
| GRKNRSSVKTPEPVV | 1271 | Q14676 | |
| GPGREVAATRPKTTK | 276 | Q96JG8 | |
| GIGKVKRKPSVPDSA | 76 | P16333 | |
| SEKNGVPARPGTEKT | 681 | Q9HCH0 | |
| RRDVPPDTITKKAGS | 1361 | Q96NW7 | |
| RTSGTTAAPRVKEGP | 526 | Q99607 | |
| PVDKKSSRPAGKGVE | 176 | O95714 | |
| VVGRLKTGTPPRIAK | 231 | Q9Y2Z2 | |
| ATPKVKSGVRRAEPA | 631 | Q9UPA5 | |
| KSGVRRAEPATPVVK | 636 | Q9UPA5 | |
| PKPRLTSSVKELGGV | 361 | Q08426 | |
| EAPKRGSILSKPRAG | 46 | O43526 | |
| VVKVSDRGKPPRYGT | 791 | Q08174 | |
| SSSLGRKTPGPKDRI | 711 | O15018 | |
| KGEKASTGRVPPSRE | 591 | P35663 | |
| KSEGPPGKVRKRTTI | 116 | Q96MZ4 | |
| SSEKGGRLPTPKLRE | 506 | Q8TC05 | |
| TKSRPETPKQKGESR | 696 | Q6KC79 | |
| GPVSKTEGFPKDSRI | 351 | Q9ULI3 | |
| PEATTPGKRVDSKIR | 221 | Q8N594 | |
| RGSKSPKTPTGLRRG | 521 | Q76FK4 | |
| SGKTPERTEASAKPR | 166 | Q9P242 | |
| RKGGPAPVDRKAKAS | 46 | O75081 | |
| MGTPASGRKRTPVKD | 1 | Q9Y608 | |
| ARPKGLSTLVKSGVP | 526 | Q5R372 | |
| AKGFGPPVTTRIATK | 571 | O14522 | |
| TSGGTKVPLEARPVR | 41 | Q9HAB8 | |
| KTGGSRKRSPEVRAP | 331 | B2RXH4 | |
| KARAGEEGPRPTKES | 286 | Q9HAH7 | |
| VAPEIKPGKSVRGSV | 2136 | Q4G0P3 | |
| GRKPAGLISASRKVP | 26 | P22492 | |
| VSRKRKAPASPGAGS | 6 | Q5T6F0 | |
| TGYRVRVTPKEKTGP | 1841 | P02751 | |
| GPGIKKTERRARSSP | 241 | Q53EP0 | |
| KGPSKLVAQRRTGPT | 6 | Q9BUT9 | |
| DRGVTRSKAEKVRPP | 11 | A6NN90 | |
| GLPLPKRSVTVTKDG | 986 | Q86VF2 | |
| GEKGISTARPKIISP | 316 | Q902F9 | |
| PKTGKSKIGSIPRDT | 2081 | Q8NDH2 | |
| TPKAEPRRRKGLTTG | 21 | Q08E93 | |
| AGKRKASGPPVSELI | 31 | P16402 | |
| LKKVRVVPPTTTSGG | 401 | P49336 | |
| GRRSSKPPVAKVKCG | 1826 | Q9C0D2 | |
| VSESDSPVKRPGRKA | 46 | P18858 | |
| PATVDAAVPGAGKKR | 491 | Q6NYC8 | |
| ERAGSGSQVPTEPKK | 91 | P31431 | |
| KPVRKELTSSGGPTK | 251 | Q96EE3 | |
| PRVKDSSPGEKSRSQ | 896 | Q99590 | |
| PSTGAPSKKSVARIG | 311 | P30260 | |
| RTSEKLVKGPRDGPA | 366 | Q2VPK5 | |
| AGLTVKPSGKPRRKS | 496 | Q9BV36 | |
| GEVRTRDKKGVTIPS | 156 | P60484 | |
| RSKPKLVSTTGAVPG | 811 | P23468 | |
| KTRKTTTTPGRKPRG | 71 | P17096 | |
| CSGRLKTPGKREIPV | 646 | Q9UF33 | |
| RVVSAPVGKETPSKR | 216 | Q13416 | |
| IPASKTPVGGDRKKS | 506 | Q96C24 | |
| SEAGKVDREGTPRKP | 501 | Q3SY00 | |
| PSAVPGLSKTSGRRV | 876 | Q8N1G1 | |
| ETPTLFKRTPGGAKE | 211 | Q6PI48 | |
| RASGPPAKATEAGKR | 6 | Q9NNX9 | |
| PRSVGQPSRRKAKSG | 1071 | Q7Z5M5 | |
| RASGPPAKAKETGKR | 6 | O14598 | |
| PKSPGTTRKDNIGRS | 1161 | O43426 | |
| VRAASAPAKESPRKG | 436 | Q13428 | |
| PPITGGASELAKRKV | 71 | Q6ZQX7 | |
| IEARGLTPKPGSKSL | 176 | Q9UJD0 | |
| SGIGTPPSVLKRQRK | 401 | P10244 | |
| PKAGVTGSEPRKASL | 86 | A0PJY2 | |
| PKTEAQGITGARPKT | 86 | Q96D09 | |
| DKSRGSRPGKSPERS | 2126 | O75376 | |
| SKPGGLPRRSSIIKD | 96 | Q9UPR0 | |
| APKPGEEVKSEGTAR | 511 | Q8NDX1 | |
| DVTPIPSDSTRRKGG | 131 | P62263 | |
| VASPRPVKGKAGRET | 51 | Q9BZQ2 | |
| RSLTRGPGKETPSKD | 11 | Q8TF17 | |
| SSRIQCKVPPRGKDG | 1066 | P08F94 | |
| IIIGRKPGSTSSPKA | 801 | O00444 | |
| STTKIKPLGPARASG | 751 | Q9UQ84 | |
| TRGPGRVSCKNIKPE | 91 | Q9H2X0 | |
| VSPKRGRPAATEVKI | 176 | O75475 | |
| RRVISTAKAPGAIGP | 6 | P52758 | |
| TKTSRCAKGGPLSPR | 2021 | O15417 | |
| RRGPPGLEDTTSKKK | 11 | O94966 | |
| PATTPEARVLGKDGK | 1286 | Q8NI27 | |
| KVEERGKEGPGTPTR | 271 | Q05516 | |
| GDKVSSERKPVAGPT | 2306 | Q9C0A1 | |
| RASGPPAKATEAGKR | 6 | Q9H322 | |
| KRGKFVRVPSGVAPS | 36 | Q9NZQ8 | |
| IGSPRLLSVKGSPKV | 1276 | Q96T58 | |
| PVGRVTGRKGLTSKE | 551 | Q9UJ98 | |
| VQKRRGGSTVPKDGP | 286 | Q92504 | |
| DSIGETPTPGASKRK | 321 | O75533 | |
| GEVPATPVKRERSGT | 256 | Q8IUW5 | |
| KEPEKRTISRPAVGS | 766 | P15498 | |
| RTPKPGSGSESGKER | 776 | Q5T1R4 | |
| RTAAGKPLPGKDVST | 2821 | Q6ZS81 | |
| ALGPKRGPSVTEKEV | 1081 | Q8IWV7 | |
| AGGVKEETRPRAPKI | 186 | Q9UJ04 | |
| EQTGRTRRSGPIKKP | 931 | Q5JSZ5 | |
| PPVGRGTGKRVLTAK | 541 | Q8WVM7 | |
| GTEKAAPGIKPSVRK | 591 | O43151 | |
| LPKKRKRDPGSVGDT | 1736 | Q14997 | |
| RASGPPAKATEAGKR | 6 | Q9H320 | |
| STKRKKGQVPGPARS | 3786 | Q96JG9 | |
| TGTGTPVKRVRKAIE | 1016 | Q9H582 | |
| VSKPIGISKPVSVGR | 206 | Q96KM6 | |
| RGSNTFTVVPKRKPG | 496 | Q4KMQ1 | |
| RKAVVLPGGTATSPK | 421 | Q8N1G0 | |
| GTSEPEKSLRKGRPA | 1031 | Q70CQ4 | |
| TTTPKRGRPKGNISR | 836 | Q9C0G0 | |
| KGPRVKSTRPGSSDI | 161 | Q9Y6M5 | |
| YVGIPRPSGEKSIRK | 516 | Q8TB96 | |
| PKVIRSDGAPAEGKR | 11 | Q13769 | |
| VSTPRDRFKEGIPGK | 56 | Q15937 | |
| PERKSERGSLGVPKT | 626 | Q68DK2 | |
| KKRRATGDGSSPELP | 1016 | Q9H2Y7 | |
| RRGPAGKKAPETCST | 141 | Q86VY4 | |
| PLGSRSVRITVKGPA | 251 | P82987 | |
| KTKGRGFTPVVDDPV | 791 | O76041 |